According to WHO, it is estimated that depression affects more than 300 million people. It is the 4th leading cause of disability worldwide; in adolescents it is the leading cause of suicide. About 800,000 people commit suicide each year, and suicide is the second leading cause of death in the 15-29 age group. Therefore, there is a greater need to address new therapeutic alternatives such as medical cannabis for the management and control of these conditions and to improve the quality of life of those who suffer from them.
In this audiobook, you will understand if there are possibilities that cannabinoids -those substances derived from cannabis- can be indicated for the treatment of patients diagnosed with this disorder. And for this, you must know the history, epidemiology, risk factors, stages, alteration in systems and how the diagnosis is made, you will also learn all about the incredible endocannabinoid system and how it is involved in the regulation of mood, its distribution in the body, its receptors and all the homeostatic-physiological functions it performs in our central nervous system, as well as some clinical studies that show that phytocannabinoids -especially CBD- can be used as a possible antidepressant treatment for a satisfactory clinical evolution of the patient.
If you are interested in learning more about the benefits of medical cannabis and how it can improve the quality of life of people who are affected by depression, we invite you to enjoy this audiobook that Pharmacology University brings to you.
